GORDON D. MCLAREN, MD Professor Emeritus University of California, Irvine, School of Medicine Irvine, CA https://apnews.com/press-release/access-newswire/gordon-d-mclaren-medication-medical-research-1e3fc5cc70c355aedceded1138188a34 Dr. Gordon D. McLaren celebrates a diverse career, having spent 51 years as a physician and 44 as an educator. At the University of California (UC) Irvine Medical Center, he taught in the division of hematology and oncology for 23 years before retiring in 2021. Following his retirement, he was named professor emeritus and remains involved in research and teaching. After graduating from the University of Missouri in 1965 with a Bachelor of Arts in chemistry, Dr. McLaren entered Stanford University’s medical program. He graduated from Stanford University in 1970 with a Doctor of Medicine and completed an internship in internal medicine at Bassett Medical Center, affiliated with Columbia University. He then served two years as a commissioned officer in the U.S. Public Health Service at the Centers for Disease Control and Prevention (CDC) in Atlanta. Subsequently, he completed postgraduate medical education at Case Western Reserve University in Cleveland, Ohio. Dr. McLaren commenced his teaching career in 1977 as a member of the faculty at Case Western Reserve University School of Medicine in the division of hematology and oncology. In 1986, he moved to the University of North Dakota, becoming chief of the division of hematology/oncology and serving as chief of the oncology/hematology section at the VA Medical Center. In 1998, he accepted a teaching position at UC Irvine and continued to work as a physician, serving in the VA Long Beach Healthcare System. Dr. McLaren’s career is marked by groundbreaking research and the successful acquisition of research grants. Since retiring, he has continued his involvement as a distinguished alumni member of the American Society of Hematology. Looking ahead, Dr. McLaren hopes to continue conducting research actively. His areas of research interest are focused mainly on disorders of iron metabolism, including hemochromatosis and other forms of iron overload, control of intestinal iron absorption and regulation of cellular iron-binding proteins. We can make better progress by collaborating with other people having different areas of expertise, and by bringing our expertise together to focus on the same problem.
RkJQdWJsaXNoZXIy MTQ5NDA2